News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement

Bronwyn Kunhardt

Advertisement

Bronwyn Kunhardt

Articles by Bronwyn Kunhardt

The Importance of Risk Intelligence in the Supply Chain

ByBronwyn Kunhardt
November 16th 2015

Leaders should understand the key themes of risk intelligence in the supply chain, writes Bronwyn Kunhardt.

Advertisement

Latest Updated Articles

  • The Importance of Risk Intelligence in the Supply Chain
    The Importance of Risk Intelligence in the Supply Chain

    Published: November 16th 2015 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Novo Nordisk Sends Amended Acquisition Proposal to Metsera

2

Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue

3

FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency

4

Roundup: Pharma Industry Forms Strategic Collaborations Bolstering Research and Development Pipelines for Autoimmune and Oncology Therapies

5

Pharma’s Next Commercial Frontier: Orchestrating Data, AI, and CRM for True Customer Centricity

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us